Quantifying Improvement in V˙o 2peak and Exercise Thresholds in Cardiovascular Disease Using Reliable Change Indices

Author:

Faricier Robin,Keltz Randi R.,Hartley Tim,McKelvie Robert S.,Suskin Neville G.,Prior Peter L.,Keir Daniel A.ORCID

Abstract

Purpose: Improving aerobic fitness through exercise training is recommended for the treatment of cardiovascular disease (CVD). However, strong justifications for the criteria of assessing improvement in key parameters of aerobic function including estimated lactate threshold (θLT), respiratory compensation point (RCP), and peak oxygen uptake (V˙o 2peak) at the individual level are not established. We applied reliable change index (RCI) statistics to determine minimal meaningful change (MMCRCI) cutoffs of θLT, RCP, and V˙o 2peak for individual patients with CVD. Methods: Sixty-six stable patients post-cardiac event performed three exhaustive treadmill-based incremental exercise tests (modified Bruce) ∼1 wk apart (T1-T3). Breath-by-breath gas exchange and ventilatory variables were measured by metabolic cart and used to identify θLT, RCP, and V˙o 2peak. Using test-retest reliability and mean difference scores to estimate error and test practice/exposure, respectively, MMCRCI values were calculated for V˙o 2 (mL·min−1.kg−1) at θLT, RCP, and V˙o 2peak. Results: There were no significant between-trial differences in V˙o 2 at θLT (P = .78), RCP (P = .08), or V˙o 2peak (P = .74) and each variable exhibited excellent test-retest variability (intraclass correlation: 0.97, 0.98, and 0.99; coefficient of variation: 6.5, 5.4, and 4.9% for θLT, RCP, and V˙o 2peak, respectively). Derived from comparing T1-T2, T1-T3, and T2-T3, the MMCRCI for θLT were 3.91, 3.56, and 2.64 mL·min−1.kg−1; 4.01, 2.80, and 2.79 mL·min−1.kg−1 for RCP; and 3.61, 3.83, and 2.81 mL·min−1.kg−1 for V˙o 2peak. For each variable, MMCRCI scores were lowest for T2-T3 comparisons. Conclusion: These MMCRCI scores may be used to establish cutoff criteria for determining meaningful changes for interventions designed to improve aerobic function in individuals with CVD.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine,Pulmonary and Respiratory Medicine,Rehabilitation

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3